Valuation Metrics Signal Improved Price Attractiveness
Recent analysis reveals that Jocil Ltd’s price-to-earnings (P/E) ratio stands at 15.80, a figure that positions the stock favourably against many of its industry peers. This P/E is significantly lower than companies such as Sanstar (63.22), Stallion India (45.94), and Titan Biotech (67.14), which are classified as expensive or very expensive. Jocil’s price-to-book value (P/BV) ratio of 0.62 further underscores its undervaluation, suggesting the stock is trading below its net asset value, a rarity in the current market environment.
Other valuation multiples reinforce this attractive stance. The enterprise value to EBITDA (EV/EBITDA) ratio of 8.00 is modest compared to peers like Sanstar (54.09) and Titan Biotech (54.72), indicating a more reasonable valuation relative to earnings before interest, tax, depreciation and amortisation. Additionally, the EV to EBIT ratio of 12.18 and EV to capital employed of 0.61 highlight efficient capital utilisation and a cost-effective enterprise value.
Financial Performance and Returns Contextualised
Despite the attractive valuation, Jocil’s return metrics paint a mixed picture. The company’s return on capital employed (ROCE) is a modest 0.66%, while return on equity (ROE) stands at 3.95%. These figures suggest that while the stock is attractively priced, operational efficiency and profitability remain areas for improvement. Dividend yield is low at 0.34%, reflecting limited income generation for shareholders in the near term.
When analysing stock returns relative to the benchmark Sensex, Jocil has outperformed in the short term but lagged over longer horizons. Over the past week and month, the stock returned 8.63% and 13.84% respectively, compared to Sensex declines of -0.72% and -2.61%. Year-to-date, Jocil posted a modest 1.72% gain while the Sensex fell by 9.88%. However, over one, three, five, and ten-year periods, the stock has underperformed significantly, with a 10.77% loss over one year and a 20.51% decline over ten years, against Sensex gains of 188.69% over the same decade.
Fundamentals that don't lie! This Small Cap from Trading shows consistent growth and price strength over time. A reliable pick you can truly count on.
- - Strong fundamental track record
- - Consistent growth trajectory
- - Reliable price strength
Peer Comparison Highlights Relative Value
Within the Chemicals & Petrochemicals sector, Jocil’s valuation stands out as attractive when juxtaposed with its competitors. For instance, companies like I G Petrochems and Titan Biotech are trading at P/E multiples of 588.15 and 67.14 respectively, indicating stretched valuations. Even Nitta Gelatin, with a P/E of 15.1, is marginally cheaper but carries a higher EV/EBITDA of 9.51 compared to Jocil’s 8.00.
Interestingly, some peers such as TGV Sraac are classified as very attractive with a P/E of 9.09 and EV/EBITDA of 3.99, suggesting that while Jocil is attractively valued, there are even more compelling opportunities within the sector. Conversely, companies like Platinum Industrials and Gulshan Polyols are rated fair to attractive but trade at higher P/E ratios of 23.24 and 25.8 respectively, reinforcing Jocil’s relative valuation advantage.
Market Capitalisation and Trading Dynamics
Jocil Ltd is categorised as a micro-cap stock, which often entails higher volatility and liquidity considerations. The stock’s current price is ₹147.50, down 2.40% from the previous close of ₹151.12. The 52-week trading range spans from ₹91.25 to ₹177.80, indicating a wide price band and potential for price recovery or further correction depending on market sentiment and company performance.
On the trading day under review, the stock fluctuated between ₹145.00 and ₹152.80, reflecting moderate intraday volatility. Such price movements are typical for micro-cap stocks, where market depth and investor interest can vary significantly.
Holding Jocil Ltd from Chemicals & Petrochemicals? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Mojo Score and Rating Upgrade Reflect Changing Sentiment
MarketsMOJO’s proprietary scoring system has upgraded Jocil Ltd’s Mojo Grade from Sell to Hold as of 11 May 2026, with a current Mojo Score of 60.0. This upgrade signals a cautious but positive shift in analyst sentiment, recognising the improved valuation parameters and relative price attractiveness. The Hold rating suggests that while the stock is no longer viewed negatively, it may not yet warrant a Buy recommendation given the company’s modest profitability and mixed long-term returns.
Investors should note that the valuation upgrade from fair to attractive is a key driver behind this rating change, reflecting the stock’s potential to deliver value if operational metrics improve. However, the micro-cap status and sector volatility remain risk factors to consider.
Long-Term Outlook and Investment Considerations
Jocil Ltd’s valuation repositioning offers an interesting entry point for investors seeking exposure to the Chemicals & Petrochemicals sector at a reasonable price. The stock’s P/E and P/BV ratios suggest it is undervalued relative to many peers, and short-term price performance has outpaced the broader market. Nevertheless, the company’s low ROCE and ROE indicate that operational improvements are necessary to sustain long-term growth and justify higher valuations.
Given the stock’s historical underperformance over multi-year periods compared to the Sensex, investors should weigh the potential for recovery against inherent risks. The micro-cap classification adds a layer of liquidity and volatility risk, which may not suit all portfolios.
In summary, Jocil Ltd’s shift to an attractive valuation grade combined with a Hold rating from MarketsMOJO suggests a stock that merits attention but requires careful monitoring of financial and operational developments. Investors looking for value within the Chemicals & Petrochemicals sector may find this micro-cap an intriguing candidate, especially when contrasted with more expensive peers.
Conclusion
Jocil Ltd’s recent valuation upgrade highlights a significant change in market perception, driven by favourable price multiples and relative sector positioning. While the company’s profitability metrics remain subdued, the attractive P/E and P/BV ratios provide a compelling case for investors seeking undervalued opportunities in the Chemicals & Petrochemicals space. The Hold rating and Mojo Score of 60.0 reflect a balanced view, acknowledging both the stock’s potential and its risks.
As the market continues to navigate sector-specific challenges and broader economic conditions, Jocil’s valuation attractiveness may serve as a catalyst for renewed investor interest, provided operational performance improves to support sustainable growth.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
